Trial Profile
Linezolid IV/PO for the Treatment of Vancomycin-Resistant Enterococcus Infections in Children.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 20 Aug 2009
Price :
$35
*
At a glance
- Drugs Linezolid (Primary) ; Linezolid (Primary)
- Indications Bacteraemia; Bacterial infections; Catheter infections; Nosocomial pneumonia; Skin infections; Vancomycin-resistant enterococcal infections
- Focus Therapeutic Use
- Sponsors Pfizer
- 20 Aug 2009 New trial record